| 1. |
Rader, DJ, Daugherty, A. (2008) Translating molecular discoveries into new therapies for atherosclerosis. Nature
451, 904–913.
|
| |
| 2. |
Daugherty, A. (2002) Mouse models of atherosclerosis. Am J Med Sci
323, 3–10.
|
| |
| 3. |
Schwartz, SM, Galis, ZS, Rosenfeld, ME, et al. (2007) Plaque rupture in humans and mice. Arterioscler Thromb Vasc Biol
27, 705–713.
|
| |
| 4. |
Jackson, CL, Bennett, MR, Biessen, EA, et al. (2007) Assessment of unstable atherosclerosis in mice. Arterioscler Thromb Vasc Biol
27, 714–720.
|
| |
| 5. |
Falk, E. (1999) Stable versus unstable atherosclerosis: clinical aspects. Am Heart J
138, S421–S425.
|
| |
| 6. |
Piedrahita, JA, Zhang, SH, Hagaman, JR, et al. (1992) Generation of mice carrying a mutant apolipoprotein-E gene inactivated
by gene targeting in embryonic stem cells. Proc Natl Acad Sci USA
89, 4471–4475.
|
| |
| 7. |
Plump, AS, Smith, JD, Hayek, T, et al. (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein-E-deficient
mice created by homologous recombination in ES cells. Cell
71, 343–353.
|
| |
| 8. |
Ishibashi, S, Goldstein, JL, Brown, MS, et al. (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density
lipoprotein receptor-negative mice. J Clin Invest
93, 1885–1893.
|
| |
| 9. |
Suzuki, H, Kurihara, Y, Takeya, M, et al. (1997) A role for macrophage scavenger receptors in atherosclerosis and susceptibility
to infection. Nature
386, 292–296.
|
| |
| 10. |
Whitman, SC, Rateri, DL, Szilvassy, SJ, et al. (2002) Macrophage-specific expression of class A scavenger receptors in LDL
receptor(–/–) mice decreases atherosclerosis and changes spleen morphology. J Lipid Res
43, 1201–1208.
|
| |
| 11. |
Herijgers, N, de Winther, MP, Van Eck, M, et al. (2000) Effect of human scavenger receptor class A overexpression in bone
marrow-derived cells on lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knockout mice. J Lipid Res
41, 1402–1409.
|
| |
| 12. |
Daugherty, A, Whitman, SC, Block, AE, et al. (2000) Polymorphism of class A scavenger receptors in C57BL/6 mice. J Lipid Res
41, 1568–1577.
|
| |
| 13. |
Witztum, JL. (2005) You are right too! J Clin Invest
115, 2072–2075.
|
| |
| 14. |
Curtiss, LK. (2006) Is two out of three enough for ABCG1? Arterioscler Thromb Vasc Biol
26, 2175–2177.
|
| |
| 15. |
Paigen, B, Morrow, A, Holmes, P, et al. (1987) Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis
68, 231–240.
|
| |
| 16. |
Daugherty, A, Whitman, SC. (2003) Quantification of atherosclerosis in mice. Methods Mol Biol
209, 293–309.
|
| |
| 17. |
Baglione, J, Smith, JD. (2006) Quantitative assay for mouse atherosclerosis in the aortic root. Methods Mol Med
129, 83–95.
|
| |
| 18. |
Purcell-Huynh, DA, Farese, RV, Johnson, DF, et al. (1995) Transgenic mice expressing high levels of human apolipoprotein B
develop severe atherosclerotic lesions in response to a high-fat diet. J Clin Invest
95, 2246–2257.
|
| |
| 19. |
Tangirala, RK, Rubin, EM, Palinski, W. (1995) Quantitation of atherosclerosis in murine models: correlation between lesions
in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient
and apolipoprotein E-deficient mice. J Lipid Res
36, 2320–2328.
|
| |
| 20. |
Daugherty, A, Rateri, DL. (2005) Development of experimental designs for atherosclerosis studies in mice. Methods
36, 129–138.
|
| |
| 21. |
Nakashima, Y, Plump, AS, Raines, EW, et al. (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout
the arterial tree. Arterioscler Thromb
14, 133–140.
|
| |
| 22. |
Daugherty, A, Manning, MW, Cassis, LA. (2000) Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein
E-deficient mice. J Clin Invest
105, 1605–1612.
|
| |
| 23. |
Rosenfeld, ME, Polinsky, P, Virmani, R, et al. (2000) Advanced atherosclerotic lesions in the innominate artery of the ApoE
knockout mouse. Arterioscler Thromb Vasc Biol
20, 2587–2592.
|
| |
| 24. |
Reardon, CA, Blachowicz, L, Lukens, J, et al. (2003) Genetic background selectively influences innominate artery atherosclerosis
– Immune system deficiency as a probe. Arterioscler Thromb Vasc Biol
23, 1449–1454.
|
| |
| 25. |
Daugherty, A, Pure, E, Delfel-Butteiger, D, et al. (1997) The effects of total lymphocyte deficiency on the extent of atherosclerosis
in apolipoprotein E –/– mice. J Clin Invest
100, 1575–1580.
|
| |
| 26. |
Lu, H, Rateri, DL, Daugherty, A. (2007) Immunostaining of mouse atherosclerotic lesions. Methods Mol Med
139, 77–94.
|
| |
| 27. |
Falk, E. (2006) Pathogenesis of atherosclerosis. J Am Coll Cardiol 47, C7–C12.
|
| |
| 28. |
Daugherty, A, Zweifel, BS, Schonfeld, G. (1991) The effects of probucol on the progression of atherosclerosis in mature Watanabe
heritable hyperlipidaemic rabbits. Br J Pharmacol
103, 1013–1018.
|
| |
| 29. |
Fazio, S, Linton, MF. (1996) Murine bone marrow transplantation as a novel approach to studying the role of macrophages in
lipoprotein metabolism and atherogenesis. Trends Cardiovasc Med
6, 58–65.
|
| |
| 30. |
Whitman, SC. (2004) A practical approach to using mice in atherosclerosis research. Clin Biochem Rev
25, 81–93.
|
| |